📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.

IDEXX Laboratories Inc

Common Name

IDEXX Laboratories

Country

United States

Sector

Healthcare

Industry

Diagnostics & Research

Employees

11,000

Ticker

IDXX

Exchange

NASDAQ/NGS

Website

www.idexx.com

Description

IDEXX Laboratories, Inc. is a global leader in the medical devices sector, specializing in the development, manufacture, and distribution of diagnostic products and services for animal health, water t... Show more

Income Statement Balance Sheet Group Entities

IDEXX Laboratories's Financial Statements Preview

Below are the financial statements of IDEXX Laboratories, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?

Learn More

All figures in millions of USD	2024 as of 2024-12-31	2023 as of 2023-12-31
Assets	—	—
Current assets	—	—
Cash and cash equivalents	288.27^a	453.93^a
Accounts receivable, net	473.58^a	457.45^a
Inventories	381.88^a	380.28^a
Other current assets	256.18^a	203.6^a
Total current assets	1,399.9^a	1,495.25^a
Long-term assets	—	—
Property and equipment, net	713.12^a	702.18^a
Operating lease right-of-use assets	116.13^a	115.5^a
Goodwill	405.1^a	365.96^a
Intangible assets, net	111.68^a	84.5^a
Other long-term assets	547.52^a	496.53^a
Total long-term assets	1,893.55^a	1,764.67^a
Total assets	3,293.44^a	3,259.93^a
Liabilities and stockholders’ equity	—	—
Current liabilities	—	—
Accounts payable	114.21^a	110.64^a
Accrued liabilities	502.12^a	478.71^a
Credit facility	250^a	250^a
Current portion of long-term debt	167.79^a	75^a
Current portion of deferred revenue	33.8^a	37.2^a
Total current liabilities	1,067.92^a	951.55^a
Long-term liabilities	—	—
Deferred income tax liabilities	11.31^a	7.24^a
Long-term debt, net of current portion	449.79^a	622.88^a
Long-term deferred revenue, net of current portion	26.94^a	28.53^a
Long-term operating lease liabilities, net of current portion	97.84^a	99.67^a
Other long-term liabilities	44.34^a	65.53^a
Total long-term liabilities	630.21^a	823.85^a
Total liabilities	1,698.13^a	1,775.4^a
Stockholders’ equity	—	—
Common stock	10.78^a	10.75^a
Additional paid-in capital	1,673.86^a	1,569.57^a
Deferred stock units	5.89^a	5.53^a
Retained earnings	5,332.44^a	4,444.57^a
Accumulated other comprehensive loss	-93.65^a	-71.21^a
Treasury stock, at cost	-5,334.01^a	-4,474.68^a
Total IDEXX Laboratories, Inc. stockholders’ equity	1,595.31^a	1,484.53^a
Total liabilities and stockholders’ equity	3,293.44^a	3,259.93^a

Verified Sources Behind IDEXX Laboratories’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore IDEXX Laboratories’s data sources below and access millions more through our Disclosure Search.

a. IDEXX Laboratories's Annual Report 2024

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

IDEXX Laboratories Inc

IDEXX Laboratories's Financial Statements Preview

IDEXX Laboratories's Financial Statements Preview

Verified Sources Behind IDEXX Laboratories’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Charles River Laboratories International Inc

Revvity Inc

Quest Diagnostics Inc

IQVIA Holdings Inc

Danaher Corp

Laboratory Corporation of America Holdings